ERYTHROGEL 4 %, gel for cutaneous use tube, 30 g
Active ingredients: Erythromycin
Commercialized according to BDPMDispensing in France: Prescription only
Gel for applicationtube, 30 gcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ERYTHROGEL 4 %, gel pour application cutanée
- Pharmaceutical form
- gel pour application
- Route of administration
- cutanée
- Presentation description
- 1 tube(s) aluminium de 30 g
- Marketing authorisation holder
- LABORATOIRES BAILLEUL (LUXEMBOURG)
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Mar 1984
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65256289CIP73267092CIP133400932670925Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉRYTHROMYCINEgel | 4,00 g · 100 g de gel | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.